Liquidity & Technicals

Liquidity & Technicals

Figures converted from GBP at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, multiples, percentages, and unitless technical indicators (RSI, MACD, realized volatility) are unchanged.

The verdict in two sentences. Wise trades $21.2M of stock per day against a $17.6B market cap — a turnover ratio of 0.12% that puts the name in capacity-constrained specialist territory; a 0.5% issuer-level position needs three weeks to build or exit at 20% participation. Technically, price has clawed back above the 200-day SMA after a November death-cross sell-off, but the 50-day still trades below the 200-day and the rally has run on shrinking volume — constructive but unconfirmed.

Portfolio implementation verdict

Price snapshot

Beta is omitted: no UK broad-market benchmark series was loaded for this run, and a single-asset history without a paired index cannot anchor a defensible beta.

Trend — full price history with 50/200-day SMA

Price is above the 200-day SMA by 8.7%. The post-IPO history splits into three clean regimes: a year-long de-rating from the $12.19 direct-listing reference to the $3.25 all-time low in October 2022; a recovery through 2023–2024 that printed two golden crosses (July 2023, December 2024); and a renewed downtrend through mid-2025 that produced the November 2025 death cross. The current setup is a textbook recovery-from-death-cross — price has reclaimed the 200-day but the moving-average configuration has not confirmed.

Relative strength vs benchmark + sector

No benchmark series was successfully loaded for this run (UK broad-market ETF EWU was the intended reference). Sector ETF and peer basket are also unavailable. Relative-strength analysis is deferred — the company-only series is shown above; pair-against-index comparisons should be sourced from the Quant or Variant pages.

Momentum — RSI(14) and MACD histogram, last 18 months

RSI sits at 60.8 — bullish but not overbought; the indicator has held above 50 for most of the last six weeks, consistent with the rally. MACD is the more cautious read: the line is positive but already crossed below its signal line, and the histogram has flipped negative — momentum is decelerating even as price grinds higher. The combination is a near-term bullish-but-fading setup, the kind that often gives back recent gains before resolving in either direction.

Volume, volatility, and sponsorship

The most striking feature: the recent 16% one-month rally has run on below-average volume. The 5-day average sits near 1.0M shares against a 50-day average of 1.74M — sponsorship is not confirming the move. Combined with the MACD divergence, this is the single weakest element of the technical picture.

Top volume events (5-year window)

The 31 May 2023 print — 22.6× average volume on an 8.3% rally — coincides with Wise's FY23 full-year results and stands out as the cleanest positive earnings reaction in the post-IPO record. The other top spikes are mostly downside reactions to mid-period updates.

Realized volatility (30-day rolling, 5-year history)

Realized vol is currently 29.5% — between the 5-year p20 (25.2%) and p50 (34.7%) bands, which the methodology classifies as normal-to-calm. That matters: the recent rally is not the kind of vol-crush mean reversion that follows a panic. It is being absorbed in an orderly tape, which makes patient accumulation defensible — but also means there is no compressed-vol catalyst force-feeding upside.

Institutional liquidity panel

ADV and turnover

Fund-capacity table

Reverse the math: at a normal 20% participation rate, a fund running this name as a 5% position needs to be $425M or smaller to clear the 5-day execution test; a 2% position works up to $1.07B. At a more conservative 10% participation, those numbers halve. For most multi-billion equity funds, Wise is either a bench-position or an out-of-bench specialist sleeve — not a flagship holding.

Liquidation runway

A 0.5%-of-mcap position ($88M) takes three trading weeks to exit at full institutional aggression and over two months at a more cautious 10% rate. A 1% position is a six-to-seventeen-week project. No issuer-level position size of 0.5% or larger clears the 5-day threshold — the data field reads 0.0%.

Execution friction

The 60-day median daily range is 1.10% — under the 2% threshold above which intraday impact starts compounding. Bid-ask cost is not the problem here; the problem is sheer volume per day relative to mcap. There are no zero-volume days in the trailing 60-session window, and volume coverage is 100%. The friction is one of capacity, not of trading microstructure.

Technical scorecard and stance

Net score: +1. Stance: neutral with a bullish lean over the 3-to-6 month horizon. The recovery from the November 2025 death cross is real — price has reclaimed the 200-day SMA on a normal-vol tape — but the rally lacks the volume signature that usually accompanies a durable trend change, and the MACD has begun to fade. A break above $15.36 (the 52-week high) closes out the bearish moving-average configuration and validates the recovery; a loss of $12.71 (the 200-day SMA) marks the rally as a counter-trend bounce and reopens the path to the $10.65 52-week low. Liquidity is the constraint, not the tape: even with a constructive technical view, this is a slow-build name suitable for funds under $425M targeting a 5% weight, or larger funds willing to run it as a sub-2% specialist position over multiple weeks.